Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| NOVADEL PHARMA INC | 17,120,360 | reported | 04 Apr 2011 | tx 10+34,428,420−4,325,797 |
| AVANIR PHARMACEUTICALS | 7,125,754 | reported | 13 Oct 2009 | tx 17+1,186,919−1,778,992 |
| CADENCE PHARMACEUTICALS INC | 3,022,069 | reported | 30 Aug 2007 | tx 23−15,622 |
| ACHILLION PHARMACEUTICALS INC | 2,663,854 | reported | 17 Dec 2009 | tx 2−563,452 |
| Immune Design Corp. | 2,138,858 | reported | 12 May 2015 | tx 11−273,736 |
| UroGen Pharma Ltd. | 1,242,031 | reported | 28 Nov 2017 | tx 2−209,298 |
| MAPLE MOUNTAIN EXPLORATIONS INC. | 694,444 | reported | 09 Jan 2015 | tx 2+944,444 |
| EAGLE PHARMACEUTICALS, INC. | 149,107 | reported | 15 May 2017 | tx 24+5,137,012−8,132,660 |
| LAURIER INTERNATIONAL INC | 88,648 | reported | 12 Jan 2016 | tx 1+88,648 |
| NOVACEA INC | 12,500 | reported | 17 Jan 2007 | tx 10+1,867,775−1,470,660 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 28 Nov 2017 | SALE | UroGen Pharma Ltd. | 177,807 | 40.51 USD | anomaly |
| 27 Nov 2017 | SALE | UroGen Pharma Ltd. | 31,491 | 41.12 USD | |
| 15 May 2017 | OTHER | EAGLE PHARMACEUTICALS, INC. | 3,584,087 | 0.00 USD | |
| 15 May 2017 | OTHER | EAGLE PHARMACEUTICALS, INC. | 149,107 | 0.00 USD | |
| 15 May 2017 | OTHER | EAGLE PHARMACEUTICALS, INC. | 149,107 | 0.00 USD | |
| 12 Jan 2016 | GRANT_AWARD | LAURIER INTERNATIONAL INC | 88,648 | 0.00 USD | deriv |
| 04 Jan 2016 | GRANT_AWARD | EAGLE PHARMACEUTICALS, INC. | 15,000 | 0.00 USD | deriv |
| 12 May 2015 | SALE | Immune Design Corp. | 155,000 | 21.50 USD | anomaly |
| 12 May 2015 | SALE | Immune Design Corp. | 22,607 | 22.26 USD | |
| 21 Apr 2015 | GRANT_AWARD | EAGLE PHARMACEUTICALS, INC. | 10,000 | 0.00 USD | deriv |
| 21 Apr 2015 | SALE | Immune Design Corp. | 14,167 | 26.35 USD | |
| 20 Apr 2015 | SALE | Immune Design Corp. | 12,792 | 26.44 USD | |
| 17 Apr 2015 | SALE | Immune Design Corp. | 18,861 | 26.67 USD | |
| 13 Mar 2015 | GRANT_AWARD | EAGLE PHARMACEUTICALS, INC. | 5,000 | 0.00 USD | deriv |
| 18 Mar 2015 | SALE | Immune Design Corp. | 19,300 | 26.56 USD | |
| 18 Mar 2015 | SALE | Immune Design Corp. | 100 | 27.04 USD | |
| 17 Mar 2015 | SALE | Immune Design Corp. | 20,000 | 25.94 USD | |
| 18 Mar 2015 | SALE | Immune Design Corp. | 500 | 26.99 USD | |
| 18 Mar 2015 | SALE | Immune Design Corp. | 100 | 27.02 USD | |
| 16 Mar 2015 | SALE | Immune Design Corp. | 10,309 | 25.43 USD | |
| 09 Jan 2015 | PURCHASE | MAPLE MOUNTAIN EXPLORATIONS INC. | 694,444 | 0.00 USD | deriv |
| 09 Jan 2015 | PURCHASE | MAPLE MOUNTAIN EXPLORATIONS INC. | 250,000 | 250000.00 USD | derivanomaly |
| 08 Apr 2014 | GRANT_AWARD | EAGLE PHARMACEUTICALS, INC. | 4,680 | 0.00 USD | deriv |
| 18 Feb 2014 | CONVERSION | EAGLE PHARMACEUTICALS, INC. | 850,520 | — | |
| 18 Feb 2014 | CONVERSION | EAGLE PHARMACEUTICALS, INC. | 62,575 | — |
2 purchases reported after at least 12 months of silence — most recent on 18 Feb 2014.